- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03596541
Clinical Validation of Tele-stethoscope System Digital (TeleCáceres)
Clinical Validation of Tele-stethoscope System Digital Bluetooth Ehas-fundatel
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cáceres, Spain, 10003
- San Pedro de Alcántara Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Informed consent sign.
- Pacient admitted to hospital with any disease but no inestable disease.
Exclusion Criteria:
- The lack of informed consent.
- Inestable disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: An open real-time tele-stethoscopy system
EHAS-Fundatel digital stethoscope is an open real-time tele-stethoscopy system.
The interventions in this arm will be to make a respiratory and heart auscultation with this tele-stethoscope.
After that, we will do the comparison or agreetment between the auscultation of two protocols: tele-stethoscopy system and conventional stethoscope.
|
We compare the respiratory and heart auscultation of clinicians using the EHAS-Fundatel digital stethoscope and a conventional stethoscope and we will observe; inter-observer and intra-observer differences by two auscultation methods.
|
Active Comparator: Conventional stethoscope
Conventional stethoscope used is the 3M Littmann Classic II S.E.
stethoscope.
The interventions in this arm will be to make a respiratory and heart auscultation with this conventional stethoscope.
After that we will do the comparison or agreetment between the ascultation of two protocols: conventional stethoscope and tele-stethoscopy system.
|
We compare the respiratory and heart auscultation of clinicians using the EHAS-Fundatel digital stethoscope and a conventional stethoscope and we will observe; inter-observer and intra-observer differences by two auscultation methods.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intra-observer agreement for heart murmurs auscultation using the two methods (tele-stethoscope and conventional stethoscope)
Time Frame: change from baseline auscultation to final auscultation (after 1 hour)
|
The investigators will randomize the first auscultation (baseline auscultation) into tele-stethoscope system or conventional stethoscope. After 1 hour, we will use the other auscultation method. The investigators will measure if there is a heart murmur or not and the intra-observer agreement by the kappa index in the heart murmurs auscultation. |
change from baseline auscultation to final auscultation (after 1 hour)
|
Intra-observer agreement for heart rhythm auscultation using the two methods (tele-stethoscope and conventional stethoscope)
Time Frame: change from baseline auscultation to final auscultation (after 1 hour)
|
The investigators will measure if there is a heart rhythm auscultation or not rhythm and the intra-observer agreement by the kappa index in the heart rhythm auscultation.
|
change from baseline auscultation to final auscultation (after 1 hour)
|
Intra-observer agreement for vesicular murmur auscultation using the two methods (tele-stethoscope and conventional stethoscope)
Time Frame: change from baseline auscultation to final auscultation (after 1 hour)
|
The investigators will measure if there is a normal vesicular murmur or not and the intra-observer agreement by the kappa index in the vesicular murmur auscultation.
|
change from baseline auscultation to final auscultation (after 1 hour)
|
Intra-observer agreement for lung rales sounds using the two methods (tele-stethoscope and conventional stethoscope)
Time Frame: change from baseline auscultation to final auscultation (after 1 hour)
|
The investigators will measure if there is a lung rale sound or not and the intra-observer agreement by the kappa index in the lung rale sound.
|
change from baseline auscultation to final auscultation (after 1 hour)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inter-observer agreement for for heart murmurs auscultation using the two methods (tele-stethoscope and conventional stethoscope)
Time Frame: change from baseline auscultation to final auscultation (after 1 hour)
|
The investigators will randomize the first auscultation (baseline auscultation) into tele-stethoscope system or conventional stethoscope. After 1 hour, we will use the other auscultation method. The investigators will measure if there is a heart murmur or not and the inter-observer agreement by the kappa index in the heart murmurs auscultation. |
change from baseline auscultation to final auscultation (after 1 hour)
|
Inter-observer agreement for heart rhythm auscultation using the two methods (tele-stethoscope and conventional stethoscope)
Time Frame: change from baseline auscultation to final auscultation (after 1 hour)
|
The investigators will measure if there is a heart rhythm auscultation or not rhythm and the inter-observer agreement by the kappa index in the heart rhythm auscultation.
|
change from baseline auscultation to final auscultation (after 1 hour)
|
Inter-observer agreement for vesicular murmur auscultation using the two methods (tele-stethoscope and conventional stethoscope)
Time Frame: change from baseline auscultation to final auscultation (after 1 hour)
|
The investigators will measure if there is a normal vesicular murmur or not and the inter-observer agreement by the kappa index in the vesicular murmur auscultation.
|
change from baseline auscultation to final auscultation (after 1 hour)
|
Inter-observer agreement for lung rales sounds using the two methods (tele-stethoscope and conventional stethoscope)
Time Frame: change from baseline auscultation to final auscultation (after 1 hour)
|
The investigators will measure if there is a lung rale sound or not and the inter-observer agreement by the kappa index in the lung rale sound.
|
change from baseline auscultation to final auscultation (after 1 hour)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jaime Corral, MD, Hospital San Pedro de Alcántara. Cáceres. Spain
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- T-stethoscopy
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Disorder
-
Assistance Publique - Hôpitaux de ParisRecruitingRespiratory; Disorder, Functional, ImpairedFrance
-
Instituto Mexicano del Seguro SocialCompletedRespiratory; Disorder, Functional, ImpairedMexico
-
EMSCompletedFlu | Cold | Allergic Disorder of Respiratory System
-
University of MontanaNational Institute of Environmental Health Sciences (NIEHS)CompletedRespiratory Infection Other | Respiratory; Disorder, Functional, ImpairedUnited States
-
Verona Pharma plcCompletedChronic Obstructive Pulmonary Disorder | Inflammatory Disorder of the Respiratory TractUnited Kingdom
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DisorderUnited States, Austria, Belgium, Canada, Denmark, Germany, Italy, Spain, Sweden, United Kingdom, Peru, Brazil, South Africa, Argentina, Russian Federation, Mexico, Puerto Rico, Chile, Norway
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DisorderUnited States, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Czechia
-
Naestved HospitalCompletedPleural Effusion Due to Another Disorder (Disorder)Denmark
-
Assiut UniversityNot yet recruitingDisorder of Pleura and Pleural Cavity
-
Leiden University Medical CenterNot yet recruitingDepressive Disorder | Anxiety Disorders | Opioid Induced Respiratory Depression